Table 2.
Knowledge of HIV‐positive women about prevention and treatment mechanisms of cervical cancer in Addis Ababa health centers, February 2016
Variable | Frequency | Percentage | 95% CI |
---|---|---|---|
Good knowledge | 136 | 23.4 | 0.19–0.26 |
Poor knowledge | 445 | 76.6 | 0.73–0.8 |
Having multiple sexual partner is a risk of | 164 | 48.8 | 0.46–0.51 |
Exposure to sexual debut is a risk of cervical cancer | 88 | 26.2 | 0.21–0.3 |
Infection by virus (HPV) is a risk of cervical cancer | 40 | 11.9 | 0.08–0.15 |
Low immunity due to HIV/AIDS is a risk of cervical cancer | 21 | 6.3 | 0.04–0.08 |
Vaginal discharge is a symptom of cervical cancer | 147 | 43.8 | 0.38–0.49 |
Vaginal bleeding is a symptom of cervical cancer | 95 | 28.3 | 0.23–0.33 |
Pain during coitus is a symptom of cervical cancer | 49 | 15 | 0.11–0.18 |
Cervical cancer is preventable | 294 | 50.6 | 0.46–0.54 |
Vaccination prevents cervical cancer | 27 | 9.2 | 0.06–0.12 |
Screening prevents cervical cancer | 95 | 32.3 | 0.26–0.37 |
Cervical cancer screening age for HIV +ve women is as soon as she became positive | 111 | 19.1 | 0.16–022 |
Cervical cancer screening age for HIV‐positive women is at any age | 68 | 11.7 | 0.092–0.14 |
Cervical cancer screening frequency for HIV +ve women is every 3 years | 37 | 6.4 | 0.04–0.08 |
Cervical cancer screening frequency for HIV +ve women is every 5 years | 17 | 2.9 | 0.02–0.035 |
Don't know the screening frequency | 212 | 36.5 | 0.32–0.4 |
Cervical cancer is treatable disease | 375 | 64.5 | 0.6–0.68 |
Surgery is a treatment modality for cervical cancer | 60 | 10.3 | 0.08–0.12 |
Radiation is a treatment modality for cervical cancer | 110 | 18.9 | 0.16–0.22 |
Chemotherapy is a treatment modality for cervical cancer | 53 | 9.1 | 0.067–0.11 |
Don't know the treatment for cervical cancer screening | 390 | 67.1 | 0.63–0.7 |
Good knowledge, knowledge score of more than the mean value; Poor knowledge, knowledge score of less than the mean value.
The mean value of the knowledge is calculated by considering the responses of all study participants for the 17 knowledge‐based questions 17.